Fused gene, recombinant expression vector, antigen, preparation method and application
A technology of fusion antigen and fusion gene, applied in biochemical equipment and methods, fusion polypeptides, viral antigen components, etc., can solve the problems of difficult performance effect and many process steps, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0057] Preparation of fusion antigen based on avian influenza virus HA protein and avian adenovirus fiber2 protein:
[0058] Raw materials: Pichia pastoris GS115 and pPic9k plasmids were provided by the research group of Teacher Han Nanyu, School of Life Sciences, Yunnan Normal University; the above raw materials are also commercially available, such as: Pichia pastoris GS115 (produced by: Invitrogen TM ;Strain type: Pichia pastoris; Catalog number: C181-00; Medium: YPD medium; Growth conditions: 28-30°C, aerobic; Genotype: His4; Phenotype: Mut+; Plasmid transformation conditions: electroporation; Application: protein expression; induction method:
[0059] methanol); pPic9k plasmid (manufacturer: Invitrogen TM ;Product Name: pPIC9K Pichia Vector; Item No.: V17520)
[0060] Escherichia coli DH5α, plasmid extraction kit and restriction endonucleases ECORI and NOTI were purchased from TaKaRa-Bao Bioengineering (Dalian) Co., Ltd.; T4 DNA ligase is T4 DNA ligase, which is a comme...
Embodiment 2
[0072] The preparation of avian influenza and avian adenovirus type 4 dual genetic engineering subunit vaccine comprises the following steps:
[0073] (1) Oil phase preparation: 94 parts by weight of white oil for injection and 6 parts by weight of Siben-80 were mixed to prepare an oil phase, sterilized at 121° C. for 30 minutes, and cooled to room temperature for later use.
[0074] (2) Water phase preparation: take the fusion antigen prepared in Example 1 and dilute it into 96 parts by weight so that the content of the fusion antigen in the vaccine is 75 μg / ml, add 4 parts by weight of sterilized and cooled Tween-80, and stir until completely dissolve.
[0075] (3) Emulsification: Take 3 parts by weight of the oil phase and pour it into an emulsification tank for stirring, then slowly add 2 parts of the water phase, and emulsify for 60 minutes at an emulsification speed of 2000r / min.
[0076] (4) Subpackaging: Aseptic quantitative subpackaging, capped and sealed, and stored...
Embodiment 3
[0078] Vaccine immunity test
[0079] (1) Immune protection against bird flu (H9 subtype)
[0080] With 15 28-day-old SPF chickens, 10 of them were subcutaneously injected with 0.3 ml of avian influenza and avian adenovirus type 4 dual genetically engineered subunit vaccine (Example 2), and the other 5 were used as avian influenza challenge controls. Twenty-one days after inoculation, each chicken was intravenously injected with 0.2ml of H9 subtype avian influenza virus DA strain chicken embryotoxin (containing 2×10 7.0 EID 50). On the 5th day after the challenge, collect cotton swabs from the throat and cloaca of each chicken, mix the supernatants of the two, and inoculate 5 9-11-day-old SPF chicken embryos through the allantoic cavity, 0.2ml per embryo, and observe after incubation. At 72 hours, measure the HA titer of all chicken embryo fluids. As long as the HA titer of chicken embryo fluid in 1 chicken embryo among the 5 chicken embryos inoculated with each mixed swab...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com